Ownership history in Commodore Capital LP · 6 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in NURIX THERAPEUTICS INC (NRIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,275,000 | -1,505,055 | -39.8% | 2.87% | $43.2M | $18.97 |
| 2025 Q3 | REDUCED | 3,780,055 | -168,598 | -4.3% | 1.71% | $34.9M | $9.24 |
| 2025 Q2 | REDUCED | 3,948,653 | -30,254 | -0.8% | 3.17% | $45.0M | $11.39 |
| 2025 Q1 | ADDED | 3,978,907 | +978,907 | +32.6% | 3.48% | $47.3M | $11.88 |
As of 2025 Q4 — sorted by position size